The Food and Drug Administration proposed March 29 that the major statement in direct-to-consumer (DTC) television or radio advertisements relating to the side effects of an advertised prescription drug be presented in a “clear, conspicuous, and neutral manner.”
The proposed rule, published in the Federal Register (
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.